Pharmacokinetic parameters (mean ± SD) obtained for flubendazole (FLBZ) after its administration (5 mg/kg) as different formulations to uninfected jirds: Cyclodextrin-based (FLBZ-CD<sub>oral</sub> or FLBZ-CD<sub>sc</sub>) and Tween-based (FLBZ-TWEEN) formulations.

NIAID Data Ecosystem2026-03-08 收录

数据链接：

https://figshare.com/articles/dataset/_Pharmacokinetic_parameters_mean_SD_obtained_for_flubendazole_FLBZ_after_its_administration_5_mg_kg_as_different_formulations_to_uninfected_jirds_Cyclodextrin_based_FLBZ_CD_oral_or_FLBZ_CD_sc_and_Tween_based_FLBZ_TWEEN_formulations_/1039522 数据链接链接失效反馈

官方服务：

资源简介：

Cmax: peak plasma concentration; Tmax: time to peak plasma concentration; AUC0-LOQ: area under the concentration vs. time curve from 0 up to the limit of quantification. Different letters indicate statistically significant differences (P<0.05) between experimental groups.

创建时间：

2014-05-29

Pharmacokinetic parameters (mean ± SD) obtained for flubendazole (FLBZ) after its administration (5 mg/kg) as different formulations to uninfected jirds: Cyclodextrin-based (FLBZ-CD<sub>oral</sub> or FLBZ-CD<sub>sc</sub>) and Tween-based (FLBZ-TWEEN) formulations.

资源简介：

相关数据集